Subscribe to RSS
DOI: 10.1055/s-0031-1277153
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
A Gene Polymorphism in Acetyl-Coenzyme A Carboxylase Beta may be Associated with the C-Reactive Protein Level in a Prediabetic and Diabetic Population
Publication History
received 22.03.2011
first decision 06.04.2011
accepted 08.04.2011
Publication Date:
06 May 2011 (online)
Abstract
A recent study reported a significant association between the T-allele in intron 18 of the acetyl-coenzyme A carboxylase beta (ACACB) gene (C>T polymorphism) and nephropathy caused by diabetes mellitus (DM). Considering the involvement of chronic inflammation in the pathophysiology of DM, the present study investigated an association between the ACACB gene polymorphism and high-sensitivity C-reactive protein (hsCRP) in a prediabetic and diabetic population. Anthropometric and biochemical variables including hsCRP were measured among 91 Japanese subjects (mean age: 69 years) with a hemoglobin A1c level of ≥5.6% and no history of cardiovascular disease. All subjects were genotyped by an allele-specific DNA assay. The subjects with the T-allele (n=32) showed significantly higher hsCRP levels than those without the T-allele (median level: 0.17 vs. 0.14 mg/dL, P≤0.05). Similarly, the hsCRP levels continued to differ significantly, independently of the other variables, between the subjects with and without the T-allele after adjusting for multiple variables. The present data suggest that the ACACB gene C>T polymorphism may therefore be associated with chronic inflammation in this population.
Key words
high-sensitivity CRP - chronic inflammation - insulin resistance
References
- 1 Abu-Elheiga L, Oh W, Kordari P. et al . Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA. 2003; 100 (18): 10207-10212
- 2 Bakker SJ, Gansevoort RT, Stuveling EM. et al . Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?. Curr Hypertens Rep. 2005; 7 (5): 379-384
- 3 Baud L, Ardaillou R. Tumor necrosis factor alpha in glomerular injury. Kidney Int Suppl. 1994; 45 (Suppl): S32-S36
- 4 Deckert T, Kofoed-Enevoldsen A, Nørgaard K. et al . Microalbuminuria: Implications for micro- and macrovascular disease. Diabetes Care. 1992; 15 (9): 1181-1191
- 5 Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index?. Lancet. 1996; 347 (8994): 132
- 6 Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009; 94 (9): 3171-3182
- 7 Imai E, Horio M, Nitta K. et al . Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11 (2): 41-50
- 8 Maeda S, Kobayashi MA, Araki S. et al . A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet. 2010; 6 (2): e1000842
- 9 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 (7): 412-419
- 10 Nakagami T, Tominaga M, Nishimura R. et al . Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract. 2007; 76 (2): 251-256
- 11 Ono T, Shiga N, Tanabe Y. et al . The fasting-plasma glucose range in which insulin resistance measured by homeostasis model assessment correlates with euglycemic clamping (in Japanese with English abstract). J Jpn Diabetes Soc. 1999; 42 (12): 1005-1011
- 12 Saraheimo M, Teppo AM, Forsblom C. et al . Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia. 2003; 46 (10): 1402-1407
- 13 Taniguchi A, Nakai Y, Fukushima M. et al . Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes. 1992; 41 (12): 1540-1546
Correspondence
Kazuhiko KotaniPhD, MD
Division of Preventive Medicine
Clinical Research Institute
National Hospital Organization
Kyoto Medical Center
1–1 Fukakusa Mukaihata-cho
Fushimi-ku Kyoto
612-8555
Japan
Phone: +81/285/58 7386
Fax: +81/285/44 9947
Email: kazukotani@jichi.ac.jp